{UTF-8}
abandoning bioproducts=
	fossil product is favorable * (Adopters - bioproduct offtake agreement magnitude * bioproduct offtake agreement duration\
		)/retrofit delay
	~	ton/Month/Month
	~	going to be dependent on the quantity (Adopters - bioproduct offtake \
		agreement magnitude * bioproduct offtake agreement duration), which is the \
		amount of Adopters available for abandoning - consumers under the \
		agreement won't abandon
	|

fossil product long term cost trend=
	0.01
	~	USD/ton/year [-10,10,0.1]
	~		|

bioproduct marketing=
	0.0011
	~	Dmnl [0,5]
	~		|

fossil product actual cost=
	MAX(2.5, 10 + fossil product long term cost trend * Time)
	~	USD/ton [0,?]
	~	The MAX structure is to prevent the actual cost from going below the \
		reasonable minimum of 2.50
	|

overcoming inertia=
	NonAdopters * bioproduct marketing / consumer inertia +
	Adopters * effective contact rate * NonAdopters / (consumer inertia * (NonAdopters +\
		 Potential Adopters + Adopters))
	~	 [0,?]
	~	NonAdopters * bioproduct marketing / consumer inertia = captures effectiveness of \
		advertisements and similar information, mitigated by the level of inertia \
		potential consumers have (consumer inertia > 1 = less likely to adopt)
		Second term is the impact from word of moutn - see \
		https://help.anylogic.com/index.jsp?topic=%2Fcom.anylogic.help%2Fhtml%2FSDT\
		%2FBass+Diffusion+Model.html for equation source, again mitigated by \
		consumer inertia
	|

effective contact rate=
	2
	~	Dmnl [0,200]
	~		|

bioproduct market share=
	Adopters / (Potential Adopters + NonAdopters + Adopters + 0.001)
	~	Dmnl [0,1]
	~	adding the 0.001 on the bottom prevents ever dividing by zero
	|

Adopters= INTEG (
	bioproduct offtake agreement magnitude * bioproduct offtake agreement duration +
	deciding to adopt+new adopters-abandoning bioproducts,
		0)
	~	ton/Month
	~		|

Potential Adopters= INTEG (
	overcoming inertia-deciding to adopt,
		0)
	~	ton/Month [0,?]
	~	these are consumers/production capacities who are **still purchasing \
		fossil products** but have overcome the inertia that prevents them from \
		being sensitive to bioproduct price advantages
	|

bioproduct is favorable=
	IF THEN ELSE(fossil product perceived cost > bioproduct perceived cost, 1, 0)
	~	Dmnl [0,1]
	~		|

new adopters=
	bioproduct is favorable * market expanding
	~	tons/Month/Month [0,?]
	~		|

bioproduct offtake agreement magnitude=
	1000
	~	tons/Month [0,?]
	~	arbitrary number
	|

new nonadopters=
	market expanding * fossil product is favorable
	~	tons/Month/Month [0,?]
	~		|

NonAdopters= INTEG (
	abandoning bioproducts+new nonadopters-overcoming inertia,
		initial market size)
	~	tons/Month [0,?]
	~	these are consumers/production capacities who are subject to inertia in \
		other words they are not sensitive to bioproduct price advantages - other \
		factors keep them purchasing fossil products
	|

market expanding=
	100
	~	tons/Month/Month [0,?]
	~	arbitrary number
	|

deciding to adopt= DELAY FIXED (
	 bioproduct is favorable * Potential Adopters , retrofit delay , 0)
	~	tons/Month/Month [0,?]
	~	the retrofit delay can be set to zero to represent a direct replacement
	|

New Market Participants= INTEG (
	market expanding-new adopters-new nonadopters,
		0)
	~	tons/Month [0,?]
	~		|

fossil product is favorable=
	IF THEN ELSE(fossil product perceived cost <= bioproduct perceived cost, 1, 0)
	~	Dmnl [0,1]
	~	to be updated if necessary with inertia stuff
	|

retrofit delay=
	12
	~	Month [0,?]
	~	**For direct replacements, this parameter should be set to 0 representing \
		no retrofit delay
	|

bioproduct effectiveness=
	1
	~	Dmnl [0,?]
	~	For performance-advantaged bioproducts, this number is likely to be greater than 1 \
		indicating that the product is more efficient/effective/less is needed \
		relative to the incumbent product
		** For direct replacement bioproducts this parameter must be set equal to \
		1, by definition
	|

bioproduct perceived cost=
	bioproduct actual cost *
	( 1 / bioproduct effectiveness ) *
	( 1 + quality disruption perceived cost * (1 - bioproduct quality reliability)
	  + supply disruption perceived cost * (1 - bioproduct supply reliability) )
	~	USD/ton
	~	effectiveness greater than 100% (relative to incumbent product) lowers cost while \
		effectiveness less than 100% (ditto) increases the cost
		NOTE: direct replacement products will always have bioproduct \
		effectiveness = 1, thus it has no effect on the perceived cost
	|

marginal supply reliability gain=
	1
	~	
	~		|

cumulative production impact on bioproduct quality reliability=
	1
	~	
	~		|

bioproduct supply reliability= WITH LOOKUP (
	marginal supply reliability gain * Cumulative Production / one ton,
		([(0,0)-(200,100)],(0,0.6),(100,0.99),(200,0.99) ))
	~	Dmnl
	~	(1 - supply reliability) is a percent (fraction) that multiplies the cost \
		of supply disruption - such that if reliability is 100% then there is no \
		cost of disruption, and if reliability is less than 100% disruption cost \
		increases as reliability decreases
	|

Cumulative Production= WITH LOOKUP (
	Time,
		([(0,0)-(100,3e+06)],(0,0),(36,97000),(48,267089),(60,437168),(72,607247),(84,1.33773e+06\
		),(96,2.06821e+06),(100,2.3117e+06) ))
	~	tons [0,?]
	~	this is a fake stock emulating the actual Cumulative Production stock from \
		the full btd. Demo production is assumed to be included here. Demoing \
		takes 3 years to complete and the plant continues operation during 3 more \
		years while the commercial plant is constructed, and then the commercial \
		plant immediately comes online at full capacity.
	|

bioproduct quality reliability= WITH LOOKUP (
	cumulative production impact on bioproduct quality reliability * Cumulative Production\
		 / one ton,
		([(0,0)-(200,10)],(0,0.8),(30,0.99),(100,0.99),(200,0.99) ))
	~	Dmnl
	~	(1 - quality reliability) multiplies the cost of quality disruption, such \
		that 100% reliability means the disruption cost incurred is zero and \
		decreasing reliability increases the disruption cost incurred
	|

consumer aversion to disruption=
	0.25
	~	Dmnl [-5,5,0.1]
	~		|

consumer inertia=
	1.5
	~	Dmnl
	~	replace with a function reflecting one of the chosen inertia behavior \
		patterns
	|

bioproduct actual cost=
	10
	~	USD/ton
	~		|

fossil product perceived cost=
	fossil product actual cost *
	(
	1 + quality disruption perceived cost * (1 - fossil product quality reliability)
	  + supply disruption perceived cost * (1 - fossil product supply reliability)
	)
	~	USD/ton [0,?]
	~		|

fossil product quality reliability=
	0.99
	~	Dmnl [0,1]
	~		|

fossil product supply reliability=
	0.99
	~	Dmnl [0,1]
	~		|

bioproduct offtake agreement duration=
	PULSE( 5 , 120 )
	~	Dmnl [0,?]
	~	time units are in Months so this is a 10-year offtake agreement that \
		starts 5 months into the model
	|

initial market size=
	100000
	~	tons [0,?]
	~	arbitrary number
	|

one ton=
	1
	~	tons [1,1]
	~		|

quality disruption actual cost=
	0.5
	~	Dmnl [0,5,0.1]
	~	interpret as a percentage of the actual product (fossil or d.r.) cost
	|

quality disruption perceived cost=
	quality disruption actual cost + 0.1 * consumer aversion to disruption
	~	Dmnl [0,?]
	~	this is a percent of the actual product cost but can be greater than 100%
	|

supply disruption actual cost=
	0.5
	~	Dmnl [0,5,0.1]
	~	interpret as percentage of the actual product (fossil or d.r. cost)
	|

supply disruption perceived cost=
	supply disruption actual cost + 0.15 * consumer aversion to disruption
	~	Dmnl [0,?]
	~	this is a percent of the actual cost but can be greater than 100%
	|

********************************************************
	.Control
********************************************************~
		Simulation Control Parameters
	|

FINAL TIME  = 100
	~	Month
	~	The final time for the simulation.
	|

INITIAL TIME  = 0
	~	Month
	~	The initial time for the simulation.
	|

SAVEPER  = 
        TIME STEP
	~	Month [0,?]
	~	The frequency with which output is stored.
	|

TIME STEP  = 1
	~	Month [0,?]
	~	The time step for the simulation.
	|

\\\---/// Sketch information - do not modify anything except names
V300  Do not put anything below this section - it will be ignored
*View 1
$192-192-192,0,Times New Roman|12||0-0-0|0-0-0|0-0-255|-1--1--1|-1--1--1|96,96,95,0
10,1,fossil product actual cost,1474,198,43,19,8,3,0,0,0,0,0,0
10,2,bioproduct actual cost,1527,468,56,19,8,3,0,0,0,0,0,0
10,3,fossil product is favorable,258,558,50,19,8,3,0,0,0,0,0,0
10,4,consumer inertia,412,238,53,16,8,131,0,0,0,0,0,0
10,5,consumer aversion to disruption,1347,373,59,19,8,3,0,0,0,0,0,0
10,6,bioproduct supply reliability,1287,558,58,19,8,3,0,0,0,0,0,0
10,7,bioproduct quality reliability,1463,557,58,19,8,3,0,0,0,0,0,0
10,8,fossil product supply reliability,1347,189,51,19,8,3,0,0,0,0,0,0
10,9,fossil product quality reliability,1240,168,51,19,8,3,0,0,0,0,0,0
10,10,bioproduct market share,474,398,59,19,8,3,0,0,0,0,0,0
10,11,fossil product perceived cost,1337,293,47,19,8,3,0,0,0,0,0,0
10,12,bioproduct perceived cost,1352,449,47,19,8,3,0,0,0,0,0,0
1,13,2,12,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1454,446)|
1,14,1,11,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1437,248)|
10,15,supply disruption perceived cost,1542,366,54,19,8,3,0,0,0,0,0,0
10,16,quality disruption perceived cost,1182,369,54,19,8,3,0,0,0,0,0,0
1,17,6,12,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1304,505)|
1,18,8,11,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1334,239)|
1,19,15,11,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1439,308)|
1,20,16,11,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1239,310)|
1,21,15,12,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1463,396)|
1,22,16,12,0,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1260,406)|
10,23,fossil product perceived cost,408,650,52,19,8,2,0,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
10,24,bioproduct perceived cost,667,652,52,19,8,2,0,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
1,25,23,3,0,0,0,0,0,128,0,-1--1--1,,1|(339,607)|
1,26,24,3,0,0,0,0,0,128,0,-1--1--1,,1|(468,606)|
1,27,7,12,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1425,500)|
1,28,9,11,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1258,235)|
1,29,5,16,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1270,352)|
1,30,5,15,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1415,345)|
10,31,bioproduct is favorable,755,564,42,19,8,3,0,0,0,0,0,0
1,32,23,31,0,0,0,0,0,128,0,-1--1--1,,1|(579,607)|
1,33,24,31,0,0,0,0,0,128,0,-1--1--1,,1|(706,612)|
10,34,supply disruption actual cost,1678,322,54,19,8,3,0,0,0,0,0,0
10,35,quality disruption actual cost,1055,328,54,19,8,3,0,0,0,0,0,0
1,36,35,16,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1093,368)|
1,37,34,15,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(1652,361)|
10,38,TIME STEP,461,317,50,11,8,2,1,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
10,39,TIME STEP,627,320,50,11,8,2,1,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
10,40,one ton,1380,611,25,11,8,3,0,0,0,0,0,0
1,41,40,6,0,0,0,0,0,128,0,-1--1--1,,1|(1346,591)|
1,42,40,7,0,0,0,0,0,128,0,-1--1--1,,1|(1408,591)|
10,43,bioproduct offtake agreement duration,862,202,58,26,8,131,0,0,0,0,0,0
10,44,initial market size,90,239,53,11,8,3,0,0,0,0,0,0
10,45,one ton,540,299,34,11,8,2,1,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
12,46,0,1063,764,145,38,8,135,0,2,-1,0,0,0,-1--1--1,0-0-0,|12||255-0-0
add memory: experience, reliability, keep track of failures/shutdowns/decreases in production - maybe going back to demo plant as measure of initial success
12,47,0,1098,67,94,28,8,7,0,2,-1,0,0,0,-1--1--1,0-0-0,|12||255-0-0
have these dependent on time - random walks w tunable parameters
10,48,Cumulative Production,1358,755,47,27,3,131,0,0,0,0,0,0
10,49,Time,1515,783,26,11,8,2,0,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
1,50,49,48,1,0,0,0,0,64,0,-1--1--1,,1|(1447,781)|
1,51,48,6,1,0,0,0,0,128,0,-1--1--1,,1|(1295,661)|
1,52,48,7,1,0,0,0,0,128,0,-1--1--1,,1|(1436,664)|
10,53,marginal supply reliability gain,1108,650,49,19,8,3,0,0,0,0,0,0
10,54,cumulative production impact on bioproduct quality reliability,1647,657,93,28,8,3,0,0,0,0,0,0
1,55,53,6,1,0,0,0,0,128,0,-1--1--1,,1|(1192,590)|
1,56,54,7,1,0,0,0,0,128,0,-1--1--1,,1|(1561,589)|
10,57,NonAdopters,251,309,64,33,3,131,0,0,0,0,0,0
10,58,Potential Adopters,494,307,62,30,3,131,0,0,0,0,0,0
10,59,Adopters,726,305,63,28,3,131,0,0,0,0,0,0
10,60,New Market Participants,499,458,50,31,3,131,0,0,0,0,0,0
1,61,63,57,4,0,0,22,0,0,0,-1--1--1,,1|(251,396)|
1,62,63,60,100,0,0,22,0,0,0,-1--1--1,,1|(353,458)|
11,63,540,251,458,6,8,34,3,0,0,1,0,0,0
10,64,new nonadopters,251,477,54,11,40,3,0,0,-1,0,0,0
1,65,67,59,4,0,0,22,0,0,0,-1--1--1,,1|(726,391)|
1,66,67,60,100,0,0,22,0,0,0,-1--1--1,,1|(634,458)|
11,67,476,726,458,6,8,34,3,0,0,1,0,0,0
10,68,new adopters,726,477,43,11,40,3,0,0,-1,0,0,0
12,69,48,502,588,10,8,0,3,0,0,-1,0,0,0
1,70,72,60,4,0,0,22,0,0,0,-1--1--1,,1|(499,509)|
1,71,72,69,100,0,0,22,0,0,0,-1--1--1,,1|(499,560)|
11,72,48,499,535,8,6,33,3,0,0,4,0,0,0
10,73,market expanding,563,535,56,11,40,3,0,0,-1,0,0,0
1,74,76,59,4,0,0,22,0,0,0,-1--1--1,,1|(639,305)|
1,75,76,58,100,0,0,22,0,0,0,-1--1--1,,1|(579,305)|
11,76,444,609,305,6,8,34,3,0,0,1,0,0,0
10,77,deciding to adopt,609,324,55,11,40,3,0,0,-1,0,0,0
1,78,80,58,4,0,0,22,0,0,0,-1--1--1,,1|(405,307)|
1,79,80,57,100,0,0,22,0,0,0,-1--1--1,,1|(341,307)|
11,80,316,373,307,6,8,34,3,0,0,1,0,0,0
10,81,overcoming inertia,373,326,57,11,40,3,0,0,-1,0,0,0
1,82,84,57,4,0,0,22,0,0,0,-1--1--1,,1|(251,196)|
1,83,84,59,100,0,0,22,0,0,0,-1--1--1,,1|(726,196)|
11,84,140,501,196,6,8,34,3,0,0,3,0,0,0
10,85,abandoning bioproducts,501,169,39,19,40,3,0,0,-1,0,0,0
10,86,bioproduct effectiveness,1164,473,41,19,8,3,0,2,0,0,0,0,-1--1--1,0-0-0,|12||0-0-255
1,87,86,12,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(1241,448)|
1,88,72,64,1,0,0,0,0,128,0,-1--1--1,,1|(317,508)|
1,89,73,68,1,0,0,0,0,128,0,-1--1--1,,1|(660,524)|
1,90,43,59,1,0,0,0,0,128,0,-1--1--1,,1|(836,273)|
1,91,43,85,1,0,0,0,0,128,0,-1--1--1,,1|(579,133)|
1,92,44,57,1,0,0,0,0,128,1,-1--1--1,,1|(130,305)|
1,93,58,76,1,0,0,0,0,128,0,-1--1--1,,1|(581,277)|
1,94,57,80,1,0,45,0,2,128,0,-1--1--1,|0||-1--1--1,1|(333,287)|
1,95,4,80,1,0,45,0,2,128,0,-1--1--1,|0||-1--1--1,1|(400,272)|
1,97,59,85,1,0,0,0,0,128,0,-1--1--1,,1|(655,179)|
10,98,bioproduct offtake agreement magnitude,927,148,67,19,8,3,0,0,0,0,0,0
1,99,98,59,1,0,0,0,0,128,0,-1--1--1,,1|(902,270)|
1,100,98,85,1,0,0,0,0,128,0,-1--1--1,,1|(729,71)|
1,101,3,64,1,0,0,0,0,128,0,-1--1--1,,1|(212,517)|
1,102,31,68,1,0,0,0,0,128,0,-1--1--1,,1|(776,522)|
10,103,fossil product is favorable,383,113,55,19,8,2,0,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
10,104,bioproduct is favorable,567,240,47,19,8,2,0,3,-1,0,0,0,128-128-128,0-0-0,|12||128-128-128
1,105,104,77,1,0,0,0,0,128,0,-1--1--1,,1|(604,267)|
10,106,retrofit delay,661,246,40,11,8,3,0,2,0,0,0,0,-1--1--1,0-0-0,|12||0-0-255
1,107,106,77,1,0,0,0,0,128,0,-1--1--1,,1|(639,281)|
1,108,103,85,1,0,0,0,0,128,0,-1--1--1,,1|(471,121)|
1,109,57,10,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(342,384)|
1,110,58,10,1,0,45,0,2,128,0,-1--1--1,|12||0-0-0,1|(552,357)|
1,111,59,10,1,0,43,0,2,128,0,-1--1--1,|12||0-0-0,1|(598,397)|
10,113,bioproduct marketing,304,231,35,19,8,3,0,0,0,0,0,0
1,114,113,80,1,0,43,0,2,128,0,-1--1--1,|0||-1--1--1,1|(354,267)|
1,115,59,81,0,0,0,0,0,64,0,-1--1--1,,1|(553,314)|
10,116,effective contact rate,331,428,52,19,8,3,0,0,-1,0,0,0
1,117,116,81,0,0,43,0,2,64,0,-1--1--1,|0||-1--1--1,1|(350,379)|
1,118,58,81,0,0,0,0,0,64,0,-1--1--1,,1|(438,314)|
1,119,106,85,0,0,0,0,0,64,0,-1--1--1,,1|(595,214)|
10,120,Time,1351,94,26,11,8,2,0,3,-1,0,0,0,128-128-128,0-0-0,|0||128-128-128
10,121,fossil product long term cost trend,1583,125,58,19,8,3,0,0,0,0,0,0
1,122,121,1,1,0,0,0,0,128,0,-1--1--1,,1|(1537,186)|
1,123,120,1,1,0,0,0,0,128,0,-1--1--1,,1|(1465,136)|
///---\\\
:L<%^E!@
1:biop-types-2-local.vdf
1:biop-types-1-local.vdf
9:biop-types-2-local
15:0,0,0,0,0,0
19:95,0
27:0,
34:0,
4:Time
5:overcoming inertia
35:Date
36:YYYY-MM-DD
37:2000
38:1
39:1
40:2
41:0
42:1
24:0
25:100
26:100
